[Association between novel high-density lipoprotein cholesterol metabolic phenotypes and all-cause and cardiovascular disease mortality in older adults in communities in Beijing].
Sep 2026· Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi· Vol 47 9, pp.
1593-1603
· 0 citations
Medicine
TL;DR
These indicators can reveal metabolic heterogeneity and residual mortality risk which cannot be detected by traditional HDL-C concentration, suggesting their potential as auxiliary predictors for mortality risk and as tools for cardiovascular risk stratification and precision prevention in this population.
Background Cardiovascular disease (CVD) remains the leading cause of death worldwide, particularly among older adults. The glycated hemoglobin A1c-to-high-density lipoprotein cholesterol (HbA1c/HDL-C) ratio is an emerging biomarker reflecting glucolipid metabolic derangement. However, prospective evidence regarding its...
Jin Peng, Liu-Rong Yang, Qian Zhang et al.· Frontiers in Public Health· 0 citations
Background The cholesterol–HDL–glucose (CHG) index has emerged as a novel indicator for metabolic disorders, but its association with stroke risk, especially in nondiabetic individuals, remains unclear. This study aimed to investigate the relationship between the CHG index and stroke risk in middle-aged and elderly adu...
Yun-Hua Jing, Ben Lin, Chen-Yang Ge et al.· Cardiology Research· 0 citations
The global health burden of diabetes continues to grow. While the Chinese Visceral Adiposity Index (CVAI) and low-density lipoprotein cholesterol (LDL-C) are well-established risk factors for diabetes, the potential compounding effect of these factors is not well characterized. This study aimed to explore the rel...
Jingpei Dong, Fan Yang, Lei Luo et al.· Diabetology & Metabolic...· 0 citations
Investigating the impact of cumulative CHG index on CVD development in individuals with CKM syndrome stages 0–3 and compared the predictive performances of triglyceride-glucose (TyG) index and CHG index for CVD suggests that longitudinal monitoring of CHG index and TyG index may provide additional information for CVD r...
Jiabaili Wang, Qian Liu, Meng-Hui Li et al.· Frontiers in Endocrinology· 0 citations
With distinct predictive effects for the two competing fatal outcomes, CHR could act as a convenient auxiliary biomarker for long-term mortality risk evaluation and lay a foundation for future large-cohort validation of clinical thresholds.
Wen-Juan Sun, Min Li, Jun-Chuan Li et al.· Cancer Investigation· 0 citations
Elevated NHHR is independently associated with increased risks of all-cause and cardiovascular mortality in patients with CHD and T2DM, with a clear nonlinear threshold effect.
Niuniu Wang, Xue-Jin Chen, Hao-Ran Li et al.· Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.